• Ochre Bio Closes $9.6M Seed Financing Led by Khosla Ventures firstwordpharma
    June 17, 2021
    Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, today announced the closing of a $9.6M seed financing round led by Khosla Ventures, with participation from Backed VC, Apollo Health Ventures, Selvedge, Hoxton .
PharmaSources Customer Service